Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 2
2002 3
2003 3
2004 4
2005 4
2006 7
2007 9
2008 3
2009 3
2010 2
2011 5
2012 3
2013 2
2014 2
2015 1
2016 2
2017 1
2018 4
2019 5
2020 3
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.
Lee J, Robinson ME, Ma N, Artadji D, Ahmed MA, Xiao G, Sadras T, Deb G, Winchester J, Cosgun KN, Geng H, Chan LN, Kume K, Miettinen TP, Zhang Y, Nix MA, Klemm L, Chen CW, Chen J, Khairnar V, Wiita AP, Thomas-Tikhonenko A, Farzan M, Jung JU, Weinstock DM, Manalis SR, Diamond MS, Vaidehi N, Müschen M. Lee J, et al. Among authors: thomas tikhonenko a. Nature. 2020 Dec;588(7838):491-497. doi: 10.1038/s41586-020-2884-6. Epub 2020 Nov 4. Nature. 2020. PMID: 33149299 Free PMC article.
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.
Pillai V, Muralidharan K, Meng W, Bagashev A, Oldridge DA, Rosenthal J, Van Arnam J, Melenhorst JJ, Mohan D, DiNofia AM, Luo M, Cherian S, Fromm JR, Wertheim G, Thomas-Tikhonenko A, Paessler M, June CH, Luning Prak ET, Bhoj VG, Grupp SA, Maude SL, Rheingold SR. Pillai V, et al. Among authors: thomas tikhonenko a. Blood Adv. 2019 Nov 26;3(22):3539-3549. doi: 10.1182/bloodadvances.2019000692. Blood Adv. 2019. PMID: 31738832 Free PMC article.
Tilting MYC toward cancer cell death.
Harrington CT, Sotillo E, Dang CV, Thomas-Tikhonenko A. Harrington CT, et al. Among authors: thomas tikhonenko a. Trends Cancer. 2021 Nov;7(11):982-994. doi: 10.1016/j.trecan.2021.08.002. Epub 2021 Sep 2. Trends Cancer. 2021. PMID: 34481764 Review.
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.
Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, Lanauze C, Ruella M, Gazzara MR, Martinez NM, Harrington CT, Chung EY, Perazzelli J, Hofmann TJ, Maude SL, Raman P, Barrera A, Gill S, Lacey SF, Melenhorst JJ, Allman D, Jacoby E, Fry T, Mackall C, Barash Y, Lynch KW, Maris JM, Grupp SA, Thomas-Tikhonenko A. Sotillo E, et al. Among authors: thomas tikhonenko a. Cancer Discov. 2015 Dec;5(12):1282-95. doi: 10.1158/2159-8290.CD-15-1020. Epub 2015 Oct 29. Cancer Discov. 2015. PMID: 26516065 Free PMC article.
MYC and the art of microRNA maintenance.
Psathas JN, Thomas-Tikhonenko A. Psathas JN, et al. Among authors: thomas tikhonenko a. Cold Spring Harb Perspect Med. 2014 Apr 15;4(8):a014175. doi: 10.1101/cshperspect.a014175. Cold Spring Harb Perspect Med. 2014. PMID: 24737842 Free PMC article. Review.
RNA-binding proteins of COSMIC importance in cancer.
Choi PS, Thomas-Tikhonenko A. Choi PS, et al. Among authors: thomas tikhonenko a. J Clin Invest. 2021 Sep 15;131(18):e151627. doi: 10.1172/JCI151627. J Clin Invest. 2021. PMID: 34523614 Free article. Review.
Exons of Leukemia Suppressor Genes: Creative Assembly Required.
Asnani M, Thomas-Tikhonenko A. Asnani M, et al. Among authors: thomas tikhonenko a. Trends Cancer. 2018 Dec;4(12):796-798. doi: 10.1016/j.trecan.2018.10.005. Epub 2018 Oct 28. Trends Cancer. 2018. PMID: 30470300 Free PMC article. Review.
Whence thrombospondin?
Thomas-Tikhonenko A, Iruela-Arispe ML. Thomas-Tikhonenko A, et al. Cancer Biol Ther. 2004 Apr;3(4):406-7. doi: 10.4161/cbt.3.4.737. Epub 2004 Apr 29. Cancer Biol Ther. 2004. PMID: 15107618 No abstract available.
73 results